SCHEMBL3146394

SCHEMBL3146394

B.CSCCCCCCN1CCOCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
KEAP1 Q14145 1/20 0.48
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
DUSP3 P51452 1/20 0.41
PAOX Q6QHF9 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
LMNA P02545 1/20 0.40
PKM P14618 1/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 4/20 0.40
SIGMAR1 Q99720 2/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
HTR2A P28223 1/20 0.40
MAPK1 P28482 1/20 0.40
SCN1A P35498 1/20 0.40
HTR2B P41595 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27075316 0.98 POLB (0.51) POLBSMN1; SMN2KEAP1KDM4EHPGD
SCHEMBL16669203 0.98 POLB (0.51) POLBSMN1; SMN2KEAP1KDM4EHPGD
SCHEMBL8202013 0.96 POLB (0.53) POLBSMN1; SMN2KEAP1KDM4EHPGD
SCHEMBL9881188 0.94 KEAP1 (0.54) POLBSMN1; SMN2KEAP1KDM4EHPGD
SCHEMBL6037476 0.81 HSP90AA1 (0.47) POLBSMN1; SMN2KEAP1KDM4EHPGD
SCHEMBL7103406 0.81 KEAP1 (0.68) POLBSMN1; SMN2KEAP1KDM4EHPGD
SCHEMBL9740021 0.81 KEAP1 (0.68) POLBSMN1; SMN2KEAP1KDM4EHPGD
SCHEMBL11609926 0.81 KEAP1 (0.68) POLBSMN1; SMN2KEAP1KDM4EHPGD
SCHEMBL9738476 0.81 KEAP1 (0.68) POLBSMN1; SMN2KEAP1KDM4EHPGD
SCHEMBL16173592 0.81 KEAP1 (0.68) POLBSMN1; SMN2KEAP1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220274985-A1 PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2022-09-01 US disclosed
EP-3990455-A1 PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2022-05-04 EP disclosed
CN-114269744-A Methods for preparing Toll-like receptor modulator compounds 吉利德科学公司 2022-04-01 CN disclosed
US-20210017170-A1 PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2021-01-21 US disclosed
WO-2020264081-A1 PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2020-12-30 WO disclosed
US-20100076086-A1 PROCESS FOR THE PREPARATION OF O-DESMETHYL VENLAFAXINE Merck Development Centre Private Limited Plot 1 A/2 (IN) 2010-03-25 US disclosed
EP-2114862-A1 PROCESS FOR THE PREPARATION OF O-DESMETHYL VENLAFAXINE Merck Generics (UK) Limited (GB) 2009-11-11 EP disclosed
WO-2008093142-A1 PROCESS FOR THE PREPARATION OF O-DESMETHYL VENLAFAXINE GENERICS [UK] LIMITED (GB) 2008-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220274985-A1 PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS TLR4, TLR3, TLR6 POLB 2605/4885SMN1; SMN2 3233/4885KEAP1 840/4885
US-20210017170-A1 PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS TLR4, TLR3, TLR6 POLB 2605/4885SMN1; SMN2 3233/4885KEAP1 840/4885
US-20100076086-A1 PROCESS FOR THE PREPARATION OF O-DESMETHYL VENLAFAXINE COMT, CYP3A5, MAOB POLB 671/4885SMN1; SMN2 2377/4885KEAP1 3613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.